These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34981653)

  • 1. The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.
    Ma M; Zhu J; Yang Y; Wang X; Jin Y; Zhang J; Wu S
    Cancer Med; 2022 Mar; 11(6):1542-1552. PubMed ID: 34981653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
    Ma MJ; Wang YN; Zhu JF; Wang XY; Jin YB; Liu XN; Wu SF; Yang YB
    Curr Probl Cancer; 2021 Dec; 45(6):100761. PubMed ID: 34154817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: A cross-sectional study based on post-vaccination period 2019 to 2023.
    Mo B; Ye Y; Yu M; Tong X; Cao H; Du C; Luo J; Xie C
    Cancer Med; 2024 Aug; 13(16):e70148. PubMed ID: 39189602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
    Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
    Hooi DJ; Lissenberg-Witte BI; de Koning MNC; Pinedo HM; Kenter GG; Meijer CJ; Quint WG
    Sex Transm Infect; 2018 Jun; 94(4):263-267. PubMed ID: 29021405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.
    Wang H; Cheng X; Ye J; Xu X; Hong Y; Sui L; You Z; Xie X
    BMC Cancer; 2018 Apr; 18(1):487. PubMed ID: 29703167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.
    Joura EA; Ault KA; Bosch FX; Brown D; Cuzick J; Ferris D; Garland SM; Giuliano AR; Hernandez-Avila M; Huh W; Iversen OE; Kjaer SK; Luna J; Miller D; Monsonego J; Munoz N; Myers E; Paavonen J; Pitisuttithum P; Steben M; Wheeler CM; Perez G; Saah A; Luxembourg A; Sings HL; Velicer C
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1997-2008. PubMed ID: 25274978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
    Xu XX; Zhou JS; Yuan SH; Yu H; Lou HM
    Int J Environ Res Public Health; 2015 Sep; 12(9):10794-805. PubMed ID: 26404339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of single human papillomavirus 53 infection: a retrospective study of 419 cases.
    Chen R; Fu Y; You B; Li Y; Yao Y; Wang X; Cheng X
    BMC Infect Dis; 2021 Nov; 21(1):1158. PubMed ID: 34781884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
    Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
    Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or cervical intraepithelial neoplasia in Henan province, central China.
    Chen G; Zheng P; Gao L; Zhao J; Wang Y; Qin W
    J Med Virol; 2020 Dec; 92(12):3743-3749. PubMed ID: 31930525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China.
    Chan PK; Cheung TH; Li WH; Yu MY; Chan MY; Yim SF; Ho WC; Yeung AC; Ho KM; Ng HK
    Int J Cancer; 2012 Aug; 131(3):692-705. PubMed ID: 21976212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal.
    Diop-Ndiaye H; Sastre-Garau X; Drame A; Dembele B; Ba NN; Diop-Diongue O; Mbow M; Diakhaby MEB; Woto-Gaye G; Toure Kane C; Diop M
    J Med Virol; 2021 Aug; 93(8):5110-5117. PubMed ID: 33851737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
    Kind AB; Pavelyev A; Kothari S; El Mouaddin N; Schmidt A; Morais E; Guggisberg P; Lienert F
    BMC Public Health; 2020 May; 20(1):671. PubMed ID: 32398057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2-3.
    Gonzalez-Bosquet E; Gibert M; Serra M; Hernandez-Saborit A; Gonzalez-Fernandez A
    Int J Gynecol Cancer; 2020 Jul; 30(7):954-958. PubMed ID: 32467333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
    Ruan Y; Li H; Liu M; Cao G; Xu X; Han L; Li F
    Cancer Epidemiol; 2023 Jun; 84():102372. PubMed ID: 37119603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18-25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016.
    Welby S; Rosillon D; Feng Y; Borys D
    Expert Rev Vaccines; 2022 Mar; 21(3):407-413. PubMed ID: 34939897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.